Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.

Pediatric blood & cancer - 1 Feb 2013

Morales La Madrid Andres, Nall Melanie Beglin, Ouyang Karen, Minor Agata, Raca Gordana, Kent Paul, Miller Ira, Schleiermacher Gudrun, Janoueix-Lerosey Isabelle, Cohn Susan L

Abstract excerpt

Surgery alone is curative for most children with localized MYCN-non-amplified neuroblastoma. However, 10-15% will develop recurrent loco-regional disease, and very rarely, patients will relapse metastatically. Currently, it is not possible to predict which child with localized, MYCN-non-amplified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to In Situ Hybridization, Fluorescence

Share to Neoplasm Invasiveness

Share to Neoplasm Metastasis

Share to Neuroblastoma

Share to Oligonucleotide Array Sequence Analysis

Source

Identifiers

PMID: 22997192
DOI: 10.1002/pbc.24311

Genes

MYCN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22997192-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.PMID 22997192Read ↗

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)Semantic proximity Read ↗

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectSemantic proximity Read ↗

Molecular cytogenetic characterization of two non-MYCN amplified neuroblastoma cell lines with complex t(11;17).Semantic proximity Read ↗

Significance of <i>MYCN</i> Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group DatabaseSemantic proximity Read ↗

Genomic and clinical analyses of 2p24 and 12q13‐q14 amplification in alveolar rhabdomyosarcoma: A report from the Children's Oncology GroupSemantic proximity Read ↗

Accumulation of Segmental Alterations Determines Progression in NeuroblastomaSemantic proximity Read ↗

Overall Genomic Pattern Is a Predictor of Outcome in NeuroblastomaSemantic proximity Read ↗

Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplificationSemantic proximity Read ↗

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.Semantic proximity Read ↗

A specific chromosomal abnormality in rhabdomyosarcomaSemantic proximity Read ↗

Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.Semantic proximity Read ↗

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.